Standout Papers
Citation Impact
Citing Papers
A family of Acrp30/adiponectin structural and functional paralogs
2004
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Neurogenesis in the Hypothalamus of Adult Mice: Potential Role in Energy Balance
2005 Science
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
2005 StandoutScience
Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis
2004
Pioglitazone Ameliorates Insulin Resistance and Diabetes by Both Adiponectin-dependent and -independent Pathways
2006
Inhaled Corticosteroids
2003
Progress and challenges in anti-obesity pharmacotherapy
2017
Dynamics of fat cell turnover in humans
2008 StandoutNature
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α
2003
Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy
2007
Central nervous system control of food intake and body weight
2006 StandoutNature
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Testosterone Use in Men and Its Effects on Bone Health. A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
2006
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
2014 StandoutNature
Pharmacological Treatment of the Overweight Patient
2007
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler®
2002
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
The metabolic syndrome
2010 Standout
Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals
2005
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
2004 Standout
A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma
2002
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Vitamin D Deficiency
2007 Standout
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
2008
C‐Reactive Protein (CRP)‐Lowering Agents
2006
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 Standout
Bile acid sequestrants
2011
Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
2000
Adiponectin: a link between excess adiposity and associated comorbidities?
2002
Treatment of Postmenopausal Osteoporosis
1998
Differential Regulation of Adiponectin Secretion from Cultured Human Omental and Subcutaneous Adipocytes: Effects of Insulin and Rosiglitazone
2002
Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking
1999
1 The Discovery and Development of Atorvastatin, A Potent Novel Hypolipidemic Agent
2002
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Pharmacological and surgical treatments for obesity
2006
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Esophagitis Associated with the Use of Alendronate
1996
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Biomedical applications of bisphosphonates
2013
Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin
2003
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity
2004
Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age
1998
The Intestinal Absorption of Biliary and Dietary Cholesterol as a Drug Target for Lowering the Plasma Cholesterol Level
2003
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Suppression of Niacin-induced Vasodilation with an Antagonist to Prostaglandin D2 Receptor Subtype 1
2007
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1999 StandoutNature
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression
2002
Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy
2003
Adiponectin: a relevant player in PPARγ-agonist-mediated improvements in hepatic insulin sensitivity?
2005
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo
2004
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Non‐High‐Density Lipoprotein Cholesterol: An Alternate Target for Lipid‐Lowering Therapy
2004
Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia
2002
Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor γ Agonists
2005
The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade
2001
THE PATHOPHYSIOLOGY AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
1997
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation
2004
Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease
2007
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Effects of TNF-α neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome
2007
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Regulation of insulin sensitivity by adipose tissue-derived hormones and inflammatory cytokines
2004
Statin-Associated Myopathy
2003
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Lipid overload and overflow: metabolic trauma and the metabolic syndrome
2003
Effects of Rexinoids on Glucose Transport and Insulin-mediated Signaling in Skeletal Muscles of Diabetic (db/db) Mice
2004
Long-Term Prospective and Controlled Studies Demonstrate Adipose Tissue Hypercellularity and Relative Leptin Deficiency in the Postobese State
2005
Biochemical Markers of Bone Metabolism: An Overview
1997
Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin
2004
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women
1997
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
2000
Effect of thiazolidinediones on body weight in patients with diabetes mellitus
2003
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Osteoporosis in Men
2008
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
2005 Standout
Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome
2004
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
2008
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A Prospective Study
1998
Considerations for Development of Surrogate Endpoints for Antifracture Efficacy of New Treatments in Osteoporosis: A Perspective
2008
Prevention of Nonvertebral Fractures by Alendronate
1997
Adiponectin and its role in the obesity-induced insulin resistance and related complications.
2004
Adipose Tissue
2006
Dyslipidemia: Reduction in Estimated Risk for Coronary Artery Disease After Use of Ezetimibe with a Statin
2007
Noninvasive assessment of bone mineral and structure: State of the art
1996
Bone Resorption by Osteoclasts
2000 StandoutScience
Pharmacological and surgical treatment of obesity.
2004
Adiponectin and Adiponectin Receptors
2005 Standout
Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)
1998
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Association Between Adiponectin and Mediators of Inflammation in Obese Women
2003
Type 2-diabetes og det metaboliske syndrom - diagnostik og behandling
2000
An Improved and Scalable Process for the Synthesis of Ezetimibe: An Antihypercholesterolemia Drug
2009
A Transgenic Mouse with a Deletion in the Collagenous Domain of Adiponectin Displays Elevated Circulating Adiponectin and Improved Insulin Sensitivity
2003
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
Changes in Bone Mineral Density, Lean Body Mass and Fat Content as Measured by Dual Energy X-Ray Absorptiometry in Patients With Prostate Cancer Without Apparent Bone Metastases Given Androgen Deprivation Therapy
2002
Pharmacologic Therapy for Type 2 Diabetes Mellitus
1999
Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial
1998
Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease
2004
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Adiponectin: a Regulator of Energy Homeostasis
2003
Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength
2000
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial
2010
Efficacy and Safety of a New HMG-CoA Reductase Inhibitor, Atorvastatin, in Patients With Hypertriglyceridemia
1996
Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome
2005
The Metabolic Syndrome
2008 Standout
Induction of Adiponectin, a Fat-Derived Antidiabetic and Antiatherogenic Factor, by Nuclear Receptors
2003
Adverse events associated with hormonal therapy for prostate cancer.
2005
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Osteoporosis in Men*
1999
Bone metabolism and disease in chronic kidney disease
2003
Sexual Differentiation, Pregnancy, Calorie Restriction, and Aging Affect the Adipocyte-Specific Secretory Protein Adiponectin
2003
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
2018
Therapeutic Approaches to Bone Diseases
2000 Science
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
The Discovery of Ezetimibe: A View from Outside the Receptor
2003
Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009
Disulfide-Dependent Multimeric Assembly of Resistin Family Hormones
2004 Science
Effect of Once-Weekly Oral Alendronate on Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
2007
Works of Stuart Weiss being referenced
Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal1
2000
A Randomized Trial of the Effects of Atorvastatin and Niacin in Patients with Combined Hyperlipidemia or Isolated Hypertriglyceridemia
1998
The Cost of Reaching National Cholesterol Education Program (NCEP) Goals in Hypercholesterolaemic Patients
1998
Efficacy and safety of Simvastatin 80 mg/day in hypercholesterolemic patients
1998
The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day
1997
A dose‐ranging study of a new, once‐daily, dual‐component drug product containing niacin extended‐release and lovastatin
2003
Alendronate for the Treatment of Osteoporosis in Men
2000
Colesevelam Hydrochloride (Cholestagel)
1999
Effects of simvastatin, an HMG‐CoA reductase inhibitor, in patients with hypertriglyceridemia
2003
Effects of simvastatin and prevastatin on gonadal function in male hypercholesterolemic patients
2000
Effectiveness of Atorvastatin for Reducing Low-Density Lipoprotein Cholesterol to National Cholesterol Education Program Treatment Goals
1997
Low‐dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low‐density lipoprotein cholesterol in patients with primary hypercholesterolemia
2001
Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia
2002
Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARγ Agonists: A Potential Mechanism of Insulin Sensitization
2002
Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor
1995
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1996
Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.
2003
Efficacy and Safety of Acarbose in Insulin-Treated Patients With Type 2 Diabetes
1998
Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study
1998
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout